BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics.
about
New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK.The current standard of care and the unmet needs for axial spondyloarthritisDefining the target: clinical aims in axial spondyloarthritis
P2860
BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
BSR and BHPR guideline for the ...... g spondylitis) with biologics.
@en
BSR and BHPR guideline for the ...... g spondylitis) with biologics.
@en-gb
type
label
BSR and BHPR guideline for the ...... g spondylitis) with biologics.
@en
BSR and BHPR guideline for the ...... g spondylitis) with biologics.
@en-gb
prefLabel
BSR and BHPR guideline for the ...... g spondylitis) with biologics.
@en
BSR and BHPR guideline for the ...... g spondylitis) with biologics.
@en-gb
P2093
P2860
P50
P356
P1433
P1476
BSR and BHPR guideline for the ...... ng spondylitis) with biologics
@en
P2093
Ashok Bhalla
BSR and BHPR Standards, Guidelines and Audit Working Group
Claire Riddell
David Marshall
Debbie Cook
Gareth Jones
Helena Marzo-Ortega
Karl Gaffney
Kirsten Mackay
Liz Van Rossen
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEW223
P577
2016-08-24T00:00:00Z